Racial differences in patients with left ventricular assist devices

Area of Science:

• Cardiology
• Medical Devices
• Health Disparities

Background:

• Left ventricular assist device (LVAD) implantation is a critical treatment for advanced heart failure.
• Ethnic disparities in clinical outcomes following LVAD implantation warrant investigation.
• Specialized heart failure programs aim to provide equitable care across diverse patient groups.

Purpose of the Study:

• To examine clinical outcomes, specifically survival and readmission rates, based on ethnicity in patients receiving the HeartMate II (HM-II) LVAD.
• To test the hypothesis that treatment within a comprehensive heart failure program leads to similar survival between African American and white patients.

Main Methods:

• Retrospective review of patient data for 79 individuals who underwent HeartMate II LVAD implantation over a 2-year period.
• Analysis of demographic data, cardiomyopathy etiology, left ventricular ejection fraction, cardiac dimensions, and hypertension prevalence.
• Kaplan-Meier survival analysis and multivariable Cox regression were employed to assess survival differences.
• Readmission rates were compared between ethnic groups.

Main Results:

• No significant demographic differences were observed between white (43%), African American (42%), and other ethnicities (15%).
• African American patients presented with more non-ischemic cardiomyopathy and higher ejection fractions, while white patients had larger ventricular diameters and more ischemic cardiomyopathy.
• Unadjusted survival analysis showed an advantage for African American patients, but this was not significant after multivariable adjustment.
• No significant differences in readmissions were found between African American and white patients.

Conclusions:

• Despite baseline clinical characteristic differences, African American patients demonstrated similar survival and readmission rates compared to white patients after HeartMate II LVAD implantation.
• These findings suggest that comprehensive heart failure management may mitigate ethnic disparities in LVAD outcomes.
• Further research is needed to explore the long-term implications and underlying factors influencing these outcomes.